Skip to main content
Veterinary Medicines

Ruvax Vet Suspensie voor injectie

Not authorised
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated

Product identification

Medicine name:
Ruvax Vet Suspensie voor injectie
Ruvax Vet Suspension injectable
Ruvax Vet Injektionssuspension
Active substance:
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
    1.00
    enzyme-linked immunosorbent assay unit
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • All relevant tissues
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB03
Authorisation status:
  • Surrendered
Authorised in:
  • Belgium
Package description:
  • Ruvax Vet 50 ml Vial Suspension for injection
  • Ruvax Vet 200 ml Vial Suspension for injection
  • Ruvax Vet 20 ml Vial Suspension for injection
  • Ruvax Vet 10 ml Vial Suspension for injection
  • Ruvax Vet 2 ml Vial Suspension for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V140646
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
French (PDF)
Published on: 22/03/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
French (PDF)
Published on: 22/03/2022
German (PDF)
Published on: 22/03/2022